BioDiem Ltd. has been lucratively granted patent for BDM-I, a synthetic antimicrobial compound, reveals a recent report, the announcement for which has been made today by the company.
The report says that the granting of patent signifies that the amalgam BDM-I is now restricted to BioDiem for being used as a treatment for vulvovaginitis. Vulvovaginitis is a kind of soreness that occurs in a person's vulva or vagina.
Good News USA
- Vodafone NZ’s new ‘Red Home’ packages will offer UFB and 150 TV channels
- Vodafone NZ’s full-year profit plunged by more than two-thirds to $56 million
- Vodafone adding 34 European countries to ‘AU$5 per day’ international roaming option
- Telstra launches its new ‘Every Day Connect Data Share Packages’
- Voyager signs “multimillion-dollar deal” with submarine cable group Hawaiki